Review Article
Volume 2 Issue 9 - 2020
The Diagnosis and Management of Migraines in Adults
Angelo Soukovelos* and Jessica Christie
Medical Student, Xavier University School of Medicine, Aruba
*Corresponding Author: Angelo Soukovelos, Medical Student, Xavier University School of Medicine, Aruba.
Received: August 04, 2020; Published: August 26, 2020


Migraine is the most common a disabling brain disorder. Chronic migraine, a condition characterized as having at least 15 headache days a month, with at least 8 days of having headaches with migraine presenting features, for more than 3 months. Migraine is a disabling, under diagnosed, and under treated disorder associated with significant disability, poor health related quality of life, and high economic burden. Patients presenting with migraines experience severe headaches and transient neurological symptoms called the aura. The proper diagnosis can be made by identifying the history of the patient and physical examination findings that can differentiate primary headache disorders from secondary headache disorders. As well as clinical features which may include symptoms like blurred vision, nausea, and sensitivity to light and sound, and difficulty in concentrating. There are risk factors associated with migraines including migraine medication overuse, obesity, and stress. However there are preventative measures to overcome these risk factors such as migraine medication overuse, obesity, and stress. Once the proper diagnosis is made, it is key to have the patient on the correct treatment. To avoid inadequate related symptoms such as nausea, vertigo and other possible aggravating side effects of pharmacologic therapies. Recommended pharmacologic agents include non steroidal anti-inflammatory drugs, intranasal butorphanol, ergotamine and its derivatives, and the triptans. The purpose of this article is too discusses how to diagnosis and manage patients that are suffering from migraines.

Keywords: Chronic Migraine; Headache; Medication Overuse Headache; Migraine


  1. Bartleson J and Cutrer FM. “Migraine update”. Minnesota Medicine (2010).
  2. Elrington G. “Migraine: Diagnosis and Management”. Journal of Neurology, Neurosurgery and Psychiatry2 (2002): 10-15.
  3. Goadsby PJ., et al. “Migraine-current understanding and treatment”. New England Journal of Medicine4 (2002): 257-270.
  4. Koch T and Oakley CB. “Pediatric migraine: Diagnostic criteria and treatment: Physicians must understand current diagnostic criteria for pediatric migraine and its variants, and exercise their best clinical judgment regarding treatment”. Contemporary Pediatrics6 (2018): 22-30.
  5. Peters GL. “Migraine overview and summary of current and emerging treatment options”. The American Journal of Managed Care 25 (2019): 23-34.
  6. Teixido M and Carey J. “Migraine-More than a Headache”. Otolaryngology–Head and Neck Surgery 14 (2014): 1-14.
  7. Khairmode DV., et al. “Migraine is not just a headache”. Pharma Science Monitor1 (2018).
  8. Hirata K. “Differential diagnosis of chronic headache”. Japan Medical Association Journal3 (2004): 118-123.
  9. Park JJ., et al. “Migraine with Aura as a Stroke Mimic”. Canadian Journal of Neurological Sciences2 (2020): 242-244.
  10. Lipton RB., et al. “Migraine diagnosis and treatment: results from the American Migraine Study II”. Headache: The Journal of Head and Face Pain7 (2001): 638-645.
  11. Charles A. “Advances in the basic and clinical science of migraines”. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society5 (2009): 491-498.
  12. Steiner TJ., et al. “The prevalence and disability burden of adult migraine in England and their relationships to age, gender, and ethnicity”. Cephalalgia7 (2003): 519-527.
  13. Antonaci F., et al. “A review of current European treatment guidelines for migraine”. The Journal of Headache and Pain1 (2010): 13-19.
  14. Sprenger T and Goadsby PJ. “Migraine pathogenesis and state of pharmacological treatment options”. BMC Medicine1 (2009): 71.
  15. Rawlence E and Jones S. “Migraine management”. Evaluation 15 (2020): 13.
  16. Kirthi V., et al. “Aspirin with or without an antiemetic for acute migraine headaches in adults”. Cochrane Database of Systematic Reviews 4 (2010).
  17. Goadsby PJ. “The 'Act when Mild' study: a step forward in our understanding of early treatment in acute migraine”. Cephalalgia 2 (2008): 36-41.
  18. Derry CJ., et al. “Sumatriptan for acute migraine attacks in adults‐overview of Cochrane reviews”. Cochrane Database of Systematic Reviews 5 (2014).
  19. Harris P., et al. “A systematic review of cognitive behavioral therapy for the management of headaches and migraines in adults”. British Journal of Pain4 (2015): 213-224.
  20. Rapoport AM., et al. “Optimizing the dose of zolmitriptan for the acute treatment of migraine: A multicenter, double-blind, placebo-controlled, dose range-finding study”. Neurology5 (1997): 1210-1218.
Citation: Angelo Soukovelos and Jessica Christie. “The Diagnosis and Management of Migraines in Adults”. EC Nursing and Healthcare 2.8(2020): 45-50.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.